Autor:	InVivo Therapeutics Holdings Corp.
Zdroj:	Business Wire (English). 08/22/2013.
Abstrakt:	The Board of Directors of InVivo Therapeutics Holdings Corp. (OTCBB: NVIV) today announced that Francis M. Reynolds has resigned from his positions as Chairman, CEO and CFO of the company due to his medical condition. The Board has appointed Michael J. Astrue as interim CEO and Sean Moran, the company’s Director of Finance, as acting CFO, effective immediately. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.